-
Heart Disease? Interested in Exercise?
Participants with a history of heart disease with symptoms of depression may qualify for a research study evaluating the effects of exercise or medication on symptoms of depression and important cardiovascular risk markers.
Updated:
Nov. 4, 2009
-
Response of Myocardial Ischemia to Escitalopram Treatment (REMIT)
Do you have heart disease? Have you had a heart attack, stent, or bypass surgery?
Updated:
Oct. 6, 2009
-
Aim High
This study is being done to see if combination therapy (Zocor® plus Niaspan®) will reduce the risk for coronary heart disease death, heart attack, and stroke more than statin therapy (Zocor®) alone.
Updated:
Mar. 11, 2009
-
Phase I Study of the Combination of Gemcitabine Plus Dasatinib in Patients With Refractory Solid Tumors With an Expanded Cohort in Advanced Pancreatic Cancer
Participate in a clinical trial for patients with refractory solid tumors.
Updated:
May 14, 2009
-
Phase I Study of Capecitabine, Oxaliplatin, Bevacizumab, and Dasatinib for Patients With Advanced Solid Tumors or Metastatic Colorectal Cancer
The primary purpose of this study is to find the highest tolerated dose of the study drugs: capecitabine, oxaliplatin, bevacizumab, and dasatinib given in combination to subjects with advanced solid tumors.
Updated:
June 29, 2009
-
Phase IB Study of Sorafenib for Patient With Locally Advanced or Metastatic Carcinoma and Child's B Cirrhosis
This Phase I trial is studying the side effects and best dose of sorafenib in treating patients with locally advanced or metastatic liver cancer and cirrhosis.
Updated:
June 29, 2009
-
Infliximab in Treatment of Patients with Pemphigus Vulgaris
Patients with pemphigus vulgaris may be eligible for new study drug.
Updated:
Mar. 31, 2009
-
Female Infertility Study
If you are between the ages of 21 and 37 and are having trouble getting pregnant, you may be eligible to participate in this study.
Updated:
July 31, 2009
-
Sunitinib Plus Prednisone in Patients with Metastatic Hormone-Refractory Prostate Cancer after Failure of Docetaxel Chemotherapy
Men with metastatic hormone-refractory prostate cancer are needed to participate in a research trial.
Updated:
Oct. 8, 2009
-
Phase II Study of Oxaliplatin, Capecitabine, and Bevacizumab in the Treatment of Metastatic Esophagogastric Adenocarcinomas
Participate in a clinical trial for metastic esophagogastric adenocarcinomas.
Updated:
May 14, 2009
About This Page
URL: http://www.dukehealth.org/Search?search_string=heart&search_category=clinical_trials